Analyst Reco. Annexon, Inc.

Equities

ANNX

US03589W1027

Market Closed - Nasdaq Other stock markets 01:30:00 30/04/2024 am IST			5-day change	1st Jan Change
4.7 ^USD	0.00%		+3.41%	+3.52%

01/04	JPMorgan Raises Price Target on Annexon to $13 From $11, Maintains Overweight Rating	MT
27/03	Wells Fargo Adjusts Price Target on Annexon to $12 From $11, Maintains Overweight Rating	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

JPMorgan Raises Price Target on Annexon to $13 From $11, Maintains Overweight Rating	01/04	MT
Wells Fargo Adjusts Price Target on Annexon to $12 From $11, Maintains Overweight Rating	27/03	MT
JPMorgan Upgrades Annexon to Overweight From Neutral, Price Target is $11	01/03	MT
BofA Securities Upgrades Annexon to Buy From Neutral	21/12	MT
Exchange-Traded Funds, Equity Futures Recover Pre-Bell Thursday to Continue Rate Cut-Fueled Rally	21/12	MT
BofA Securities Upgrades Annexon to Buy From Neutral, Adjusts Price Target to $6 From $4	21/12	MT
BofA Securities Downgrades Annexon to Neutral From Buy, Adjusts Price Target to $3 From $8	26/23/26	MT
BTIG Lowers Price Target on Annexon to $7 From $15, Maintains Buy Rating	25/23/25	MT
JPMorgan Downgrades Annexon to Neutral From Overweight, Adjusts Price Target to $9 From $19	25/23/25	MT
Cantor Fitzgerald Adjusts Price Target on Annexon to $18 From $22, Maintains Overweight Rating	14/23/14	MT
Jefferies Starts Annexon at Buy With $12 Price Target	16/22/16	MT
BTIG Research Initiates Coverage on Annexon With Buy Rating, Price Target $15	09/22/09	MT
Cantor Fitzgerald Adjusts Annexon's Price Target to $22 From $27, Reiterates Overweight Rating	16/22/16	MT
HC Wainwright Lowers Annexon's Price Target to $30 From $40, Maintains Buy Rating	10/22/10	MT
Needham Adjusts Annexon's Price Target to $24 From $37, Keeps Buy Rating	08/22/08	MT
Annexon Shares Jump After HC Wainwright Initiates Coverage With Buy Recommendation	01/21/01	MT
HC Wainwright Starts Annexon at Buy With $40 Price Target	30/21/30	MT
ANNEXON : Cantor Fitzgerald Starts Annexon Biosciences at Overweight with $40 Price Target	23/21/23	MT
ANNEXON : Needham Starts Annexon at Buy With $37 Price Target	26/21/26	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer